Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
This study is ongoing, but not recruiting participants.
Study NCT00003811 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Childhood Germ Cell Tumor
Drug/Agent Toxicity by Tissue/Organ
Extragonadal Germ Cell Tumor
Ovarian Cancer
Additional conditions recognized in this trial
Neoplasms, Germ Cell and Embryonal
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Ovarian Diseases
Urogenital Neoplasms
Interventions listed in this trial
bleomycin sulfate
amifostine trihydrate
cisplatin
etoposide
conventional surgery
Additional drug interventions recognized in this trial
Amifostine
Bleomycin
Etoposide phosphate
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Pediatric Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
